Amylyx Pharmaceuticals Etf Forward View - Simple Moving Average
| AMLX Etf | USD 14.87 0.58 4.06% |
Amylyx Etf outlook is based on your current time horizon.
At this time, The relative strength index (RSI) of Amylyx Pharmaceuticals' share price is at 55. This suggests that the etf is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Amylyx Pharmaceuticals, making its price go up or down. Momentum 55
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.37) | EPS Estimate Current Year (1.53) | EPS Estimate Next Year (1.28) | Wall Street Target Price 20.2222 | EPS Estimate Current Quarter (0.43) |
Using Amylyx Pharmaceuticals hype-based prediction, you can estimate the value of Amylyx Pharmaceuticals from the perspective of Amylyx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Amylyx Pharmaceuticals using Amylyx Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Amylyx using crowd psychology based on the activity and movement of Amylyx Pharmaceuticals' stock price.
Amylyx Pharmaceuticals Implied Volatility | 1.34 |
Amylyx Pharmaceuticals' implied volatility exposes the market's sentiment of Amylyx Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amylyx Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amylyx Pharmaceuticals stock will not fluctuate a lot when Amylyx Pharmaceuticals' options are near their expiration.
The Simple Moving Average forecasted value of Amylyx Pharmaceuticals on the next trading day is expected to be 14.87 with a mean absolute deviation of 0.46 and the sum of the absolute errors of 27.19. Amylyx Pharmaceuticals after-hype prediction price | USD 14.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Amylyx Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Amylyx contract
Based on the Rule 16, the options market is currently suggesting that Amylyx Pharmaceuticals will have an average daily up or down price movement of about 0.0838% per day over the life of the 2026-03-20 option contract. With Amylyx Pharmaceuticals trading at USD 14.87, that is roughly USD 0.0125 . If you think that the market is fully incorporating Amylyx Pharmaceuticals' daily price movement you should consider acquiring Amylyx Pharmaceuticals options at the current volatility level of 1.34%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Amylyx Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Amylyx Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Amylyx Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Amylyx Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Amylyx Pharmaceuticals' open interest, investors have to compare it to Amylyx Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Amylyx Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Amylyx. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Amylyx Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Amylyx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amylyx using various technical indicators. When you analyze Amylyx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Amylyx Pharmaceuticals Simple Moving Average Price Forecast For the 3rd of February
Given 90 days horizon, the Simple Moving Average forecasted value of Amylyx Pharmaceuticals on the next trading day is expected to be 14.87 with a mean absolute deviation of 0.46, mean absolute percentage error of 0.42, and the sum of the absolute errors of 27.19.Please note that although there have been many attempts to predict Amylyx Etf prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Amylyx Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Amylyx Pharmaceuticals Etf Forecast Pattern
| Backtest Amylyx Pharmaceuticals | Amylyx Pharmaceuticals Price Prediction | Research Analysis |
Amylyx Pharmaceuticals Forecasted Value
In the context of forecasting Amylyx Pharmaceuticals' Etf value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Amylyx Pharmaceuticals' downside and upside margins for the forecasting period are 10.68 and 19.06, respectively. We have considered Amylyx Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Amylyx Pharmaceuticals etf data series using in forecasting. Note that when a statistical model is used to represent Amylyx Pharmaceuticals etf, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.5555 |
| Bias | Arithmetic mean of the errors | -0.0547 |
| MAD | Mean absolute deviation | 0.4608 |
| MAPE | Mean absolute percentage error | 0.0331 |
| SAE | Sum of the absolute errors | 27.185 |
Predictive Modules for Amylyx Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amylyx Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Amylyx Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Amylyx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amylyx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of Amylyx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amylyx Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Amylyx Pharmaceuticals' etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amylyx Pharmaceuticals' historical news coverage. Amylyx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 10.68 and 19.06, respectively. We have considered Amylyx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amylyx Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Amylyx Pharmaceuticals is based on 3 months time horizon.
Amylyx Pharmaceuticals Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as Amylyx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amylyx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amylyx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 4.19 | 0.00 | 0.01 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
14.87 | 14.87 | 0.00 |
|
Amylyx Pharmaceuticals Hype Timeline
Amylyx Pharmaceuticals is presently traded for 14.87. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Amylyx is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at 0.21%. %. The volatility of related hype on Amylyx Pharmaceuticals is about 8729.17%, with the expected price after the next announcement by competition of 14.88. About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Amylyx Pharmaceuticals was presently reported as 3.03. The company recorded a loss per share of 1.72. Amylyx Pharmaceuticals last dividend was issued on the 28th of March 1970. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Historical Fundamental Analysis of Amylyx Pharmaceuticals to cross-verify your projections.Amylyx Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Amylyx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Amylyx Pharmaceuticals' future price movements. Getting to know how Amylyx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amylyx Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORIC | Oric Pharmaceuticals | 0.04 | 11 per month | 0.00 | (0.1) | 6.63 | (4.65) | 20.28 | |
| RLAY | Relay Therapeutics | 0.15 | 8 per month | 3.36 | 0.02 | 5.60 | (5.45) | 30.68 | |
| INBX | Inhibrx Biosciences | 1.39 | 9 per month | 3.62 | 0.10 | 6.04 | (5.44) | 27.17 | |
| SNDX | Syndax Pharmaceuticals | 0.23 | 11 per month | 1.87 | 0.18 | 8.70 | (3.57) | 18.37 | |
| NKTR | Nektar Therapeutics | (1.52) | 8 per month | 0.00 | (0.16) | 6.56 | (7.77) | 20.31 | |
| ATAI | ATAI Life Sciences | (0.08) | 9 per month | 0.00 | (0.20) | 4.91 | (5.54) | 16.19 | |
| SANA | Sana Biotechnology | 0.03 | 9 per month | 0.00 | (0.02) | 12.59 | (8.77) | 25.63 | |
| PGEN | Precigen | (0.1) | 10 per month | 4.59 | 0.03 | 6.97 | (7.08) | 38.64 | |
| CVAC | CureVac NV | 0.19 | 6 per month | 0.00 | (0.10) | 3.33 | (2.80) | 18.10 | |
| IMTX | Immatics NV | 0.15 | 9 per month | 0.00 | (0.02) | 7.31 | (6.47) | 30.34 |
Other Forecasting Options for Amylyx Pharmaceuticals
For every potential investor in Amylyx, whether a beginner or expert, Amylyx Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Amylyx Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Amylyx. Basic forecasting techniques help filter out the noise by identifying Amylyx Pharmaceuticals' price trends.Amylyx Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amylyx Pharmaceuticals etf to make a market-neutral strategy. Peer analysis of Amylyx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Amylyx Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Amylyx Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Amylyx Pharmaceuticals etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amylyx Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Amylyx Pharmaceuticals etf market strength indicators, traders can identify Amylyx Pharmaceuticals entry and exit signals to maximize returns.
Amylyx Pharmaceuticals Risk Indicators
The analysis of Amylyx Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Amylyx Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting amylyx etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.91 | |||
| Semi Deviation | 3.17 | |||
| Standard Deviation | 4.06 | |||
| Variance | 16.51 | |||
| Downside Variance | 10.45 | |||
| Semi Variance | 10.06 | |||
| Expected Short fall | (3.28) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Amylyx Pharmaceuticals
The number of cover stories for Amylyx Pharmaceuticals depends on current market conditions and Amylyx Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amylyx Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amylyx Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Amylyx Pharmaceuticals Short Properties
Amylyx Pharmaceuticals' future price predictability will typically decrease when Amylyx Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amylyx Pharmaceuticals often depends not only on the future outlook of the potential Amylyx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amylyx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 68.1 M | |
| Cash And Short Term Investments | 176.5 M |
Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.